Stockscreener 앱 받기
77.55
5.32%
-4.36
시간 외 거래:
77.56
0.01
+0.01%
전일 마감가:
$81.91
열려 있는:
$80.61
하루 거래량:
19.27M
Relative Volume:
1.24
시가총액:
$195.89B
수익:
$64.17B
순이익/손실:
$17.12B
주가수익비율:
11.52
EPS:
6.73
순현금흐름:
$18.10B
1주 성능:
-10.23%
1개월 성능:
-18.57%
6개월 성능:
-29.11%
1년 성능:
-38.82%
1일 변동 폭
$75.96
$81.12
1주일 범위
$75.96
$86.27
52주 변동 폭
$75.96
$134.63
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
77.55 | 195.89B | 64.17B | 17.12B | 18.10B | 6.73 |
|
LLY
Lilly Eli Co
|
720.91 | 647.50B | 45.04B | 10.59B | 414.30M | 11.71 |
|
JNJ
Johnson Johnson
|
148.69 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
ABBV
Abbvie Inc
|
174.20 | 308.16B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
61.21 | 271.71B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
103.40 | 204.22B | 51.72B | 11.94B | 13.81B | 5.88 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Alarum Technologies Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. April 15, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire Inc.
Merck & Co., Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors – Contact ... - Eagle-Tribune
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - PR Newswire
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Investor Sues Merck Executives, Board Over Misleading Comments - Bloomberg Law News
Merck & Co Inc Says CEO Robert M. Davis's 2024 Total Compensation Was $23.2 MillionSEC Filing - MarketScreener
MRK FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK - TradingView
Investors who lost money on Merck & Co., Inc. (MRK) should contact The Gross Law Firm about - Bluefield Daily Telegraph
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money - GlobeNewswire
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Merck & Co., Inc. to Contact the Firm Today! - markets.businessinsider.com
Key Trends Shaping the Future of Pulmonary Arterial Hypertension Market:Merck & Co. Introduces Innovative F... - WhaTech
Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On - Yahoo Finance
2025-04-08 | MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NYSE:MRK | Press Release - Stockhouse
Infertility Drugs Market Is Booming Worldwide 2025-2032 | Merck & Co., Inc., Ferring Pharmaceuticals - openPR.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming DeadlinesMRK - PR Newswire
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Merck & Co., Inc. to Contact the Firm Today! - markets.businessinsider.com
Goldman Sachs raises Merck stock rating to Buy, target to $103 - Investing.com
Lost Money on Merck & Co., Inc. (MRK)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit - Morningstar
MRK FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK - TradingView
Merck & Co., Inc. Sued for Securities Law Violations - GlobeNewswire
Rising Leaders 2025: Partnerships Propel Crystal Qin’s LaNova To Record-Breaking Merck Deal - insights.citeline.com
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact The Gross Law Firm about pending Class ActionMRK - Morningstar
2025-04-06 | MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NYSE:MRK | Press Release - Stockhouse
Faruqi & Faruqi Reminds Merck Investors of the Pending - GlobeNewswire
Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - GlobeNewswire Inc.
MRK Shareholders Have Opportunity to Lead Merck & Co., Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - markets.businessinsider.com
Levi & Korsinsky Notifies Shareholders of Merck & Co., Inc.(MRK) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Merck & Co., Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights MRK - ACCESS Newswire
MRK DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors - Bluefield Daily Telegraph
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Stockhouse
MRK Investors Have Opportunity to Lead Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - The Malaysian Reserve
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky ... - Bluefield Daily Telegraph
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class ActionMRK - GlobeNewswire
Class Action Filed Against Merck & Co., Inc. (MRK)April 14, 2025 Deadline to JoinContact Levi & Korsinsky - Morningstar
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class ActionMRK - ACCESS Newswire
Merck Investors Have 'Limited Appetite' Returning to the Stock Ahead of Gardasil Reassessment, UBS Says - MarketScreener
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Pet Pharmaceuticals Market Is Booming Worldwide | Zoetis Inc., - openPR.com
MRK DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK - TradingView
How Do Investors Really Feel About Merck & Co? - Benzinga
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. S - GuruFocus
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck - Yahoo Finance
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Intellia, and Merck and Encourages Investors to Contact the Firm - GlobeNewswire
Top Analyst Reports for Amazon, Oracle & Merck - Yahoo Finance
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
자본화:
|
볼륨(24시간):